Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis
Lara A. Ray, ReJoyce Green, Daniel Roche, et al.
Addiction Biology (2019) Vol. 24, Iss. 6, pp. 1138-1152
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Szu-Yi Liu, I‐Ting Tsai, Yin-Chou Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5170-5170
Open Access | Times Cited: 102
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
Christian S. Hendershot, Michael P. Bremmer, Michael B. Paladino, et al.
JAMA Psychiatry (2025)
Closed Access | Times Cited: 1
Low-dose naltrexone inhibits colorectal cancer progression and promotes apoptosis by increasing M1-type macrophages and activating the Bax/Bcl-2/caspase-3/PARP pathway
Mingxing Ma, Xiaonan Wang, Ning Liu, et al.
International Immunopharmacology (2020) Vol. 83, pp. 106388-106388
Closed Access | Times Cited: 51
The World Federation of Societies of Biological Psychiatry guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder
Daniel Turner, Peer Briken, Joshua B. Grubbs, et al.
Dialogues in Clinical Neuroscience (2022) Vol. 24, Iss. 1, pp. 10-69
Open Access | Times Cited: 33
Medications for the Treatment of Alcohol Dependence—Current State of Knowledge and Future Perspectives from a Public Health Perspective
Iga Stokłosa, Gniewko Więckiewicz, Maciej Stokłosa, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 1870-1870
Open Access | Times Cited: 13
Pharmacological treatment for substance use disorder: A systematic review
Joaquín Mateu-Mollá, Bartolomé Pérez Gálvez, Víctor José Villanueva‐Blasco
Addictive Behaviors (2025) Vol. 163, pp. 108242-108242
Closed Access
Naltrexone Alters Neurochemical and Behavioral Parameters in a Zebrafish Model of Repeated Alcohol Exposure
Henrique Teza Bernardo, Guilherme Lodetti, Ana Caroline Salvador de Farias, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial
Lara A. Ray, ReJoyce Green, Craig K. Enders, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 9, pp. 818-828
Open Access | Times Cited: 29
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Malia A. Belnap, Kaitlin R. McManus, Erica N. Grodin, et al.
Pharmaceutical Medicine (2024) Vol. 38, Iss. 4, pp. 291-302
Open Access | Times Cited: 4
Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder
Falk W. Lohoff
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 18
Classic psychedelics and the treatment for alcoholism
Guilherme Lodetti, Rafael Mariano de Bitencourt, Eduardo Pacheco Rico
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 135, pp. 111129-111129
Closed Access | Times Cited: 3
Pharmacotherapies and Personalized Medicine for Alcohol Use Disorder: A Review
Falk W. Lohoff
Pharmacogenomics (2020) Vol. 21, Iss. 15, pp. 1117-1138
Open Access | Times Cited: 25
Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice
Raye Z. Litten, Daniel E. Falk, Megan L. Ryan, et al.
Alcoholism Clinical and Experimental Research (2019) Vol. 44, Iss. 1, pp. 23-35
Closed Access | Times Cited: 23
Reward drinking and naltrexone treatment response among young adult heavy drinkers
Corey R. Roos, Krysten W. Bold, Katie Witkiewitz, et al.
Addiction (2021) Vol. 116, Iss. 9, pp. 2360-2371
Open Access | Times Cited: 19
Haven’t lost the positive feeling: a dose-response, oral alcohol challenge study in drinkers with alcohol use disorder
Andrea C. King, Ashley Vena, Meghan M. Howe, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 11, pp. 1892-1900
Open Access | Times Cited: 13
Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology
Lindsay R. Meredith, Elizabeth M. Burnette, Steven J. Nieto, et al.
Alcohol Clinical and Experimental Research (2023) Vol. 47, Iss. 9, pp. 1629-1645
Closed Access | Times Cited: 7
Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder
Lara A. Ray, Han Du, ReJoyce Green, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 3, pp. 519-527
Open Access | Times Cited: 18
The effect of neuroimmune modulation on subjective response to alcohol in the natural environment
Lindsay R. Meredith, Erica N. Grodin, Amanda Kay Montoya, et al.
Alcoholism Clinical and Experimental Research (2022) Vol. 46, Iss. 5, pp. 876-890
Open Access | Times Cited: 9
The Added Value of Pharmacotherapy to Cognitive Behavior Therapy And Vice Versa in the Treatment of Alcohol Use Disorders: A Systematic Review
Jan van Amsterdam, Peter Blanken, Renske Spijkerman, et al.
Alcohol and Alcoholism (2022)
Open Access | Times Cited: 9
Recovery Capital Gains May Precede Craving Reduction in Opioid Use Disorder
Nicholas L. Bormann, Andrea N. Weber, Benjamin Miskle, et al.
Substance Abuse and Rehabilitation (2023) Vol. Volume 14, pp. 113-118
Open Access | Times Cited: 5
Beyond mediators: A critical review and methodological path forward for studying mechanisms in alcohol use treatment research
Samuel N. Meisel, Cassandra L. Boness, Robert Miranda, et al.
Alcohol Clinical and Experimental Research (2023) Vol. 48, Iss. 2, pp. 215-229
Open Access | Times Cited: 5
Within‐ and between‐person effects of naltrexone on the subjective response to alcohol and craving: A daily diary investigation
Jack T. Waddell, William R. Corbin, David P. MacKinnon, et al.
Alcoholism Clinical and Experimental Research (2022) Vol. 46, Iss. 3, pp. 477-491
Open Access | Times Cited: 7
Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey
Jonathan G. Leung, Prasanna P. Narayanan, Matej Markota, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 7
Momentary subjective responses to alcohol as predictors of continuing to drink during daily-life drinking episodes
Andrea M. Wycoff, Courtney A. Motschman, Sarah A. Griffin, et al.
Drug and Alcohol Dependence (2022) Vol. 241, pp. 109675-109675
Closed Access | Times Cited: 6
Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study
Lara A. Ray, Steven J. Nieto, Lindsay R. Meredith, et al.
Psychopharmacology (2023) Vol. 240, Iss. 9, pp. 1921-1930
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top